William J Maris's Net Worth
$57.3 Million
Who is William J Maris?
William J Maris has an estimated net worth of $57.3 Million. This is based on reported shares across multiple companies, which include Dave Inc./DE, Fulcrum Therapeutics, Inc., DA32 Life Science Tech Acquisition Corp., Cue Health Inc., and Arsanis, Inc..
SEC CIK
William J Maris's CIK is 0001722210
Past Insider Trading and Trends
2021 was William J Maris's most active year for acquiring shares with 3 total transactions. William J Maris's most active month to acquire stocks was the month of June. 2022 was William J Maris's most active year for disposing of shares, totalling 12 transactions. William J Maris's most active month to dispose stocks was the month of July. 2021 saw William J Maris paying a total of $14,500,000.00 for 4,935,535 shares, this is the most they've acquired in one year. In 2023 William J Maris cashed out on 297,771 shares for a total of $1,707,657.13, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dave Inc./DE (DAVE) Snapshot price: $23.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.14% | -110.00K |
$48.90 | -$5,379,000.00 | 2.03M |
May 10
| |||
Form 4
| -17.39% | -450.00K |
$48.90 | -$22,005,000.00 | 2.14M |
May 7
| |||
Form 4
| -10.32% | -297.77K |
$5.73 | -$1,707,657.13 | 2.59M |
Aug 8
| |||
Form 4
| -0.11% | -97.30K |
$0.36 | -$35,329.63 | 92.35M |
Sep 30
| |||
Form 4
| -0.80% | -748.12K |
$0.38 | -$287,012.72 | 92.45M |
Sep 27 - Sep 29
| |||
Form 4
| -0.03% | -24.18K |
$0.50 | -$12,095.34 | 93.2M |
Sep 15
| |||
Form 4
| -0.09% | -83.31K |
$0.53 | -$43,850.34 | 93.22M |
Sep 12 - Sep 13
| |||
Form 4
| -2.86% | -2.75M |
$0.62 | -$1,697,736.66 | 93.31M |
Aug 12 - Aug 15
| |||
Form 4
| -2.10% | -2.06M |
$0.76 | -$1,561,493.72 | 96.06M |
Aug 8 - Aug 10
| |||
Form 4
|
∞
| 98.11M |
—
|
—
| 98.11M |
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $7.985
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 464.29K |
—
|
—
| 464.29K |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DA32 Life Science Tech Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 4
| +181.25% | 1.45M |
$10.00 | $14,500,000.00 | 2.25M |
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cue Health Inc. (HLTH) Snapshot price: $0.2285
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.49M |
—
|
—
| 3.49M |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arsanis, Inc. (XFOR) Snapshot price: $0.8548
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 451.36K |
—
|
—
| 451.36K |
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||